The role of Nuclear Factor-kappa B signaling in human cervical cancerSam Tilborghs, Peter A. van Dam, Jérôme Corthouts et al.|Critical Reviews in Oncology/Hematology|2017Cited by 273
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Christian Rolfo, Tindara Franchina et al.|Critical Reviews in Oncology/Hematology|2017Cited by 203
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancerXuan Bich Trinh, Peter A. van Dam|British Journal of Cancer|2009Cited by 127
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Daniele Generali, Sergio Venturini et al.|Cancer Treatment Reviews|2022Cited by 35
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Daniele Generali, Mario Giuliano et al.|Cancers|2021Cited by 19